Prospective, Multicenter Phase II Trial of Non-Pegylated Liposomal Doxorubicin Combined with Ifosfamide in First-Line Treatment of Advanced/Metastatic Soft Tissue Sarcomas.
Buonadonna A, Scalone S, Lombardi D, Fumagalli A, Guglielmi A, Lestuzzi C, Polesel J, Canzonieri V, Lamon S, Giovanis P, Gagno S, Corona G, Mascarin M, Belluco C, De Paoli A, Fasola G, Puglisi F, Miolo G.
Buonadonna A, et al. Among authors: miolo g.
Cancers (Basel). 2023 Oct 18;15(20):5036. doi: 10.3390/cancers15205036.
Cancers (Basel). 2023.
PMID: 37894403
Free PMC article.